Thought Leadership
Search results
Blog | October 07, 2016
Amgen Appeals Loss of Neulasta® and Neupogen® Litigation
Read more
Blog | October 06, 2016
EDTX denies exclusion of settlement license and "real estate" apportionment
Read more
Blog | September 30, 2016
Court Orders Entry of Final Judgment of Invalidity in Ongoing Janssen v. Celltrion BPCIA Dispute
Read more
Blog | September 16, 2016
My Intellectual Property Licensor is Bankrupt — Now What?
Read more
Blog | September 06, 2016
D.Ariz excludes expert for not apportioning the rate, but OKs entire product as base
Read more
Blog | August 19, 2016
SDFL allows opinion based in part on plaintiff's licensing proposals (or offers)
Read more
Blog | August 17, 2016
EDTX questions viability of "inexorable flow" doctrine of lost profits
Read more
Blog | August 11, 2016